← Leaderboards
Aseem Z Ansari
University Of Wisconsin-Madison
$9,477,080
Attributed
$10,210,252
Total exposure
13
Grants
11
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.9M · FY2006–25$2M$1.5M$1M$500K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$10,210,252 · 13
By mechanism
R01$9,738,329 · 6
R43$435,336 · 1
P41$36,587 · 6
Top collaborators
- Tanja Mittag2 shared
- Sean Jeffries1 shared
Most similar at University Of Wisconsin-Madison
Same institution · by research overlap
- Christian Capitini$4,273,809
Others in their field
Top investigators on “Genes”
- David Heimbrook · Leidos Biomedical Research, Inc.$413,811,031
- Richard A Gibbs · Baylor College Of Medicine$338,750,128
- Barton F Haynes · Duke University$304,076,400
- Stacey Gabriel · Massachusetts Institute Of Technology$241,252,013
- Eric S Lander · Whitehead Institute For Biomedical Res$211,825,987
- Richard K. Wilson · Washington University$195,881,965
Research focus
GenesSpecificityCellsGene ExpressionPatternBaseGenetic TranscriptionProteinsTranscription FactorBinding SitesResponseTherapeutic AgentsGenomeTranscriptional RegulationDesignPropertyIn VivoGene TargetingPlaySmall MoleculeDiabetes MellitusDna BindingIn VitroBinding (Molecular Function)
Grant awards (35)
Dissecting the contributions of phase separation to yeast transcription .$515,504
R01 · FY2025 · GM
Dissecting the contributions of phase separation to yeast transcription .$515,504
R01 · FY2024 · GM
Synthetic molecules to stimulate the expression of Frataxin to ameliorate Freidreichs Ataxin$608,525
R01 · FY2022 · NS · contact PI
Synthetic molecules to stimulate the expression of Frataxin to ameliorate Freidreichs Ataxin$608,525
R01 · FY2021 · NS · contact PI
Synthetic molecules to stimulate the expression of Frataxin to ameliorate Freidreichs Ataxin$608,525
R01 · FY2020 · NS · contact PI
Revealing Masked Specificities of Human Nuclear Receptors$547,381
R01 · FY2019 · GM · contact PI
Pre-clinical development of synthetic transcription elongation factors for the treatment of Friedreich's ataxia$435,336
R43 · FY2019 · NS
Synthetic molecules to stimulate the expression of Frataxin to ameliorate Freidreichs Ataxin$426,000
R01 · FY2019 · NS · contact PI
Deciphering the molecular and physiological cues that guide CTD patterning by Bur1/Cdk9$314,177
R01 · FY2019 · GM · contact PI
Synthetic molecules to stimulate expression of the Frataxin (FXN) and ameliorate Friedreich's Ataxia (FRDA)$149,921
R01 · FY2019 · NS · contact PI
Revealing masked specificities of human Nuclear Receptors$33,874
R01 · FY2019 · GM · contact PI
Synthetic molecules to stimulate expression of the Frataxin (FXN) and ameliorate Friedreich's Ataxia (FRDA)$532,963
R01 · FY2018 · NS · contact PI
Revealing masked specificities of human Nuclear Receptors$343,874
R01 · FY2018 · GM · contact PI
Deciphering the molecular and physiological cues that guide CTD patterning by Bur1/Cdk9$314,177
R01 · FY2018 · GM · contact PI
Revealing masked specificities of human Nuclear Receptors$343,874
R01 · FY2017 · GM · contact PI
Deciphering the molecular and physiological cues that guide CTD patterning by Bur1/Cdk9$314,177
R01 · FY2017 · GM · contact PI
Revealing masked specificities of human Nuclear Receptors$386,185
R01 · FY2016 · GM · contact PI
Deciphering the molecular and physiological cues that guide CTD patterning by Bur1/Cdk9$314,177
R01 · FY2016 · GM · contact PI
Targeting Leukemia causing oncogene E2a-Pbx1 with synthetic molecules$295,769
R01 · FY2012 · CA · contact PI
Targeting Leukemia causing oncogene E2a-Pbx1 with synthetic molecules$295,769
R01 · FY2011 · CA · contact PI
STRUCTURE AND DNA BINDING STUDIES OF NANOG, SOX2, AND OCT4$8,041
P41 · FY2011 · RR · contact PI
Targeting Leukemia causing oncogene E2a-Pbx1 with synthetic molecules$304,917
R01 · FY2010 · CA · contact PI
Modular design of synthetic transcriptional regulators$242,052
R01 · FY2010 · GM · contact PI
Modular design of synthetic transcriptional regulators$125,437
R01 · FY2010 · GM · contact PI
GAL4/MED15 BINDING AND CONFORMATION STUDY$16,186
P41 · FY2010 · RR · contact PI
ATFS, POLYAMIDE SYNTHESIS$199
P41 · FY2010 · RR · contact PI
Targeting Leukemia causing oncogene E2a-Pbx1 with synthetic molecules$304,917
R01 · FY2009 · CA · contact PI
Modular design of synthetic transcriptional regulators$244,690
R01 · FY2009 · GM · contact PI
GAL4/MED15 BINDING AND CONFORMATION STUDY$12,077
P41 · FY2009 · RR · contact PI
ATFS, POLYAMIDE SYNTHESIS$76
P41 · FY2009 · RR · contact PI
SYNTHESIS OF PNA-ENCODED COMBINATORIAL PEPTIDE LIBRARIES$8
P41 · FY2009 · RR · contact PI
Targeting Leukemia causing oncogene E2a-Pbx1 with synthetic molecules$304,917
R01 · FY2008 · CA · contact PI
Modular design of synthetic transcriptional regulators$244,877
R01 · FY2008 · GM · contact PI
Modular design of synthetic transcriptional regulators$245,060
R01 · FY2007 · GM · contact PI
Modular design of synthetic transcriptional regulators$252,561
R01 · FY2006 · GM · contact PI